Pioneering since 1849
Healthcare professionals and their care for patients have always been our focus. Right from our early days as a textile manufacturer supplying gauze to Swedish hospitals.
Throughout our history, we’ve been driven by the desire to find better ways to deliver care – and support healthcare professionals.
We were the first to mass-produce wound dressings and the first to offer single-use drapes, tubular bandages and powder-free coated surgical gloves, enhancing performance in the operating room.
We’re the company behind Safetac® – the revolutionary soft silicone-based technology used in many of our wound care dressings such as Mepitel® and Mepilex® that results in less pain for patients.
We’re still innovating today – in-house, through partnerships with others and through acquisitions. And now we’re leading the way in preventing pressure ulcers, with prophylactic dressings and devices for turning and re-positioning patients.
Mölnlycke AB is founded as a textile business. By the early 1900s the company becomes one of the main gauze suppliers to Swedish hospitals.
Swabs and dressings are prepared by nurses and patients, using industrially produced gauze. Dirty gauze is often laundered and re-used.
Mölnlycke pioneers the industrial manufacturing of swabs and wound dressings in Sweden, gradually replacing hospital manual work with pre-packed products.
Mölnlycke introduces a range of new materials and techniques designed to reduce bacteria spreading. The company focuses on promoting the change from multi-use textiles to ready packed, single-use dressings, drapes and surgical gowns.
Thomas Fabo invents the revolutionary Safetac® technology, which reduces pain and tissue damage in wound management. In 1989 Mölnlycke® launches Mepitel® wound contact layer – the first product using Safetac.
Thanks to continued strong growth Surgical and Wound Care are divided into two fully-fledged business areas. Flagship wound care products include Mepitel®, Mepiform® and Mepilex®. ProcedurePak® trays are introduced in 1999.
Success continues with the introduction of BARRIER®-branded drapes and gowns. Mepilex® Border launches in 2001 to treat chronic wounds.
After the discovery that Mepilex Border is also effective at preventing pressure ulcers, Mölnlycke’s third business area, Prevention, is born.
1975 Acquired by SCA
2005 Merged with Regent Medical and Medlock Medical
2007 Acquired by Investor AB
2009 Aquired JKT
2010 Acquired Rynel
2016 Acquired Sundance